Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan.

<b>Aim: </b>Colorectal cancer is a kind of solid tumor and third most common of cancer which leads to death. It is a heterogeneous disease characterized by genetic and epigenetic aberrations. The present study was aimed to reveal the mutation at TP53 in Peshawar Pakistan.<br /> <...

Full description

Saved in:
Bibliographic Details
Main Authors: Mian Adnan Kakakhel (Author), Ihsan Ali (Author), Aamna Fayyaz (Author), Zahid Anwar (Author), Irfan Saif (Author), Ikram Khan (Author), Muhammad Jahangir (Author)
Format: Book
Published: National Scientific Medical Center, 2021-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5eebe6eb99e347e6a01c31e6004cdd24
042 |a dc 
100 1 0 |a Mian Adnan Kakakhel  |e author 
700 1 0 |a Ihsan Ali  |e author 
700 1 0 |a Aamna Fayyaz  |e author 
700 1 0 |a Zahid Anwar  |e author 
700 1 0 |a Irfan Saif  |e author 
700 1 0 |a Ikram Khan  |e author 
700 1 0 |a Muhammad Jahangir  |e author 
245 0 0 |a Mutation analysis of TP53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan. 
260 |b National Scientific Medical Center,   |c 2021-02-01T00:00:00Z. 
500 |a 1812-2892 
500 |a 2313-1519 
500 |a 10.23950/jcmk/9719 
520 |a <b>Aim: </b>Colorectal cancer is a kind of solid tumor and third most common of cancer which leads to death. It is a heterogeneous disease characterized by genetic and epigenetic aberrations. The present study was aimed to reveal the mutation at TP53 in Peshawar Pakistan.<br /> <b>Material and methods:</b> For this purpose, a total of 50 blood samples in EDTA tubes was collected from Peshawar with complete information of patients using questionnaire. The polymerase chain reaction was performed.<br /> <b>Results:</b> The results of the present study have revealed that the ratio of colorectal cancer in males is higher 62% than females (38%). Histopathological results have indicated that moderately differentiated adenocarcinoma is 25 (50%) followed by poorly differentiated adenocarcinoma 15 (30%), Well-differentiated adenocarcinoma 8 (16%), and Metastatic adenocarcinoma 2 (4%) in 50 colorectal cancer patients. The nucleotide sequence of the human TP53 gene of colorectal cancer patients was aligned with the human wild-type TP53 database sequence with NC_191170 (NCBI) using CLUSTALW. After BLASTING, the mutation was found in exon 5 and exon 7 of TP53, while no mutation was found in exon 8 of TP53. That patient in which point mutation was found in exon 5 and 7 respectively showed less survival as compared to that of colorectal cancer patients having no point mutation in the TP53 gene.<br /> <b>Conclusion:</b> The present study concluded that point mutations were found in exons 5&7 of the TP53 gene and patients having TP53 gene mutations shown less survival rate compared to colorectal cancer patients having no mutations. 
546 |a EN 
690 |a Cancer 
690 |a Mutation 
690 |a TP53 Gene 
690 |a PCR 
690 |a Blasting 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Specialties of internal medicine 
690 |a RC581-951 
655 7 |a article  |2 local 
786 0 |n Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 18, Iss 2, Pp 25-30 (2021) 
787 0 |n https://www.clinmedkaz.org/download/mutation-analysis-of-tp53-in-colorectal-cancer-peshawar-khyber-pakhtunkhwa-pakistan-9719.pdf 
787 0 |n https://doaj.org/toc/1812-2892 
787 0 |n https://doaj.org/toc/2313-1519 
856 4 1 |u https://doaj.org/article/5eebe6eb99e347e6a01c31e6004cdd24  |z Connect to this object online.